While the evidence we provide in this study suggests that autoantibodies against this peptide are rare and unlikely to be involved in the pathophysiology and onset of this condition, T cell reactivity against RFX4 peptides was sound in some narcolepsy patients, but also in healthy donors. This evidence concerns the gene RFX4 and narcolepsy.